Discontinued — last reported Q4 '25
Johnson & Johnson Acquisitions decreased by 100.0% to $1.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 99.7%, from $338.00M to $1.00M.
Large outflows indicate a period of aggressive expansion and consolidation, which carries integration risk but potential for high growth.
The net cash paid to acquire other businesses, calculated as the purchase price minus any cash already held by the targe...
Lumpy and episodic across the semiconductor industry, often occurring in cycles of industry consolidation.
cf_acquisitions| Q2 '21 | Q2 '22 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $252.00M | $0.00 | $1.81B | $13.00B | $338.00M | $1.00M | $0.00 | $14.46B | $1.00M |
| QoQ Change | — | — | -100.0% | — | +617.6% | -97.4% | -99.7% | -100.0% | — | -100.0% |
| YoY Change | — | — | -100.0% | — | — | — | — | -100.0% | +11.2% | -99.7% |
We use cookies for analytics. See our Privacy and Cookie Policy.